March 18, 2024
Medication compounding firm SCA Pharmaceuticals and the U.S. Food and Drug Administration together have asked a Connecticut federal judge to dissolve an emergency temporary restraining order blocking the agency from publishing comments related to its contested investigation of the pharmacy, with the parties saying they have executed a settlement.
January 17, 2024
In a sealed order, a Connecticut federal judge has granted a compounding pharmacy's request to block the U.S. Food and Drug Administration from publishing insights it made during a site visit last fall that could introduce unsupported concerns about the sterility of its facility.
November 22, 2023
The U.S. Food and Drug Administration said SCA Pharmaceuticals LLC can't sue the agency for recommending a voluntary recall of its Connecticut-made products following an inspection of its facility because there was no formal recall on record.
November 06, 2023
Medication compounding company SCA Pharmaceuticals LLC sued the U.S. Food and Drug Administration in Connecticut federal court Monday, alleging the agency has put it in a Catch-22 that would destroy the company: Either it recalls $36.5 million in products and shuts down a facility, or faces a notice warning the health care industry not to use its products.